These mechanisms could include enhanced tumour perfusion resulting in temporary improved oxygenation or the activation of alternative cell death signalling pathways unrelated to the ASMase-ceramide pathway, which could independently contribute to the radioenhancement effect [21,32,33]. The gene discussed is SMPD1; the disease is neoplasm.